Drugs / M. alternifolia oil
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02695901 | Mar → Dec 2016 | — | Federal University of Santa Maria | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M. alternifolia oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02695901 ↗ |
| Known as | Melaleuca alternifolia oil | “Melaleuca alternifolia oil has been considered as an alternative because of its anti-inflammatory properties.” NCT02695901 ↗ |
| Route | Oral | “rinse twice daily with 15 ml mouthrinse containing nanoparticles of M. alternifolia oil (0.3%).” NCT02695901 ↗ |